Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,089.50    11.00 (1.02%)
Bid:
1,089.00
Ask:
1,090.50
Spread: 1.50 (0.138%)
Market Cap: £3.50b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Statement

7 Jan 2010 07:00

RNS Number : 1561F
Persimmon PLC
07 January 2010
 



TRADING UPDATE - 7 JANUARY 2010

Persimmon plc announces the following update ahead of its Preliminary Results for the year ended 31 December 2009, which will be released on Tuesday 2 March 2010.

During the 12 month period to 31 December 2009 we have legally completed the sale of 8,976 new homes generating a turnover of c. £1.4 billion. Of these completions, 4,970 were achieved in the second half of 2009, an increase on the 4,006 completions achieved in the first half of 2009.

Since April 2008 the market has been very challenging. During this time we have concentrated on cash generation. By doing so, we have achieved a significant reduction in debt from £1.2 billion at April 2008 to c. £270 million at 31 December 2009 (31 December 2008: £599 million). This has been achieved by focusing closely on working capital management and strict cash control disciplines.

However we have also continued to invest in both work in progress on new and existing developments and new land acquisitions, where we have identified good opportunities at attractive margins.  We have acquired and agreed terms to acquire c. 3,000 plots during the latter months of 2009.  Of these plots over 80% are in southern markets.  Our land bank at the year end consisted of c. 61,000 plots.

In our Interim Management Statement on 16 November 2009 we commented that we had recently reserved the 1000th Persimmon home under the Government's HomeBuy Direct Scheme. We still have c. £45 million to utilise under this successful scheme from existing allocations to assist the sale of up to an additional c. 2,500 new homes.

We are therefore pleased to have received confirmation from the Homes & Communities Agency that our recent bid for funding under Kickstart 2 has been successful. We have been allocated an additional c. £50 million specifically to support potential purchasers of Persimmon homes under the HomeBuy Direct process. This will provide assistance to many first time buyers for c. 3,000 homes on c. 40 Persimmon developments across England between now and 2012.

We are currently operating from c. 370 developments throughout mainland  UK offering a wide range of family houses. This emphasis on more traditional housing is of great benefit to our business. Forward sales into 2010 are c. 40% ahead of last year at c. £640 million. This gives us a good start to the year, although as usual we await the Spring selling season with keen interest.

Whilst we will remain cautious until mortgage availability and the general economy improves, we have continued confidence in the long term future of the UK housing market.

On Tuesday 2 March 2010 details of the Group's performance for 2009 and a general market update will be provided with the announcement of our Results for the year ended 31 December 2009.

Mike Farley and Mike Killoran will host a conference call with analysts at 9:00am today. To participate please dial +44 (0203 037 9221. The password is 'Persimmon'.

For further information, please contact:

Edward Orlebar

Charlotte McMullen

Marylène Guernier

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Persimmon plc

M:Communications

Tel: +44 (0) 1904 642199

Tel: +44 (0) 20 7920 2333


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBFMRTMBAMBLM
Date   Source Headline
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:12 pmRNSTotal Voting Rights
22nd Sep 20223:54 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSHalf Year Results
1st Aug 20222:30 pmRNSTotal Voting Rights
20th Jul 20224:14 pmRNSHolding(s) in Company
13th Jul 20224:40 pmRNSHolding(s) in Company
12th Jul 20222:20 pmRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSTrading Update
4th Jul 20222:44 pmRNSHolding(s) in Company
1st Jul 20222:28 pmRNSTotal Voting Rights
27th Jun 20225:15 pmRNSHolding(s) in Company
23rd Jun 20224:46 pmRNSNew Chief Financial Officer Start Date
6th Jun 20225:28 pmRNSAdditional Listing
1st Jun 20224:38 pmRNSBlock listing Interim Review
1st Jun 202210:52 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.